Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
This guideline offers best practice advice for all women of reproductive age who may wish to regulate their fertility through the use of long-acting reversible contraceptive methods and considers specific issues for the use of these methods in women during the menarche and before the menopause. The guideline also identifies specific issues that may be relevant to particular groups, including women with HIV, learning disabilities and physical disabilities, and under-16s. | Long-acting reversible contraception the effective and appropriate use of long-acting reversible contraception National Collaborating Centre for Women s and Children s Health Commissioned by the National Institute for Health and Clinical Excellence October 2005 RCOG Press Published by the RCOG Press at the Royal College of Obstetricians and Gynaecologists 27 Sussex Place Regent s Park London NW1 4RG www.rcog.org.uk Registered charity no. 213280 First published 2005 2005 National Collaborating Centre for Women s and Children s Health No part of this publication may be reproduced stored or transmitted in any form or by any means without the prior written permission of the publisher or in the case of reprographic reproduction in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK www.cla.co.uk . Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page. The use of registered names trademarks etc. in this publication does not imply even in the absence of a specific statement that such names are exempt from the relevant laws and regulations and therefore for general use. While every effort has been made to ensure the accuracy of the information contained within this publication the publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check current indications and accuracy by consulting other pharmaceutical literature and following the guidelines laid down by the manufacturers of specific products and the relevant authorities in the country in which they are practising. ISBN 1-904752-18-7 RCOG Editor Andrew Welsh Design typesetting by FiSH Books London Index by Jill Halliday Printed by Bell amp Bain Ltd 303 Burnfield Road Thornliebank Glasgow G46 7UQ Contents Guideline Development Group membership and acknowledgements v Guideline Development Group v
